Drugs / SAV001-H
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01546818 | Mar 2012 → Mar 2013 | HIV infectious disease | Sumagen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAV001-H | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01546818 ↗ |
| Modality | Vaccine | “SAV001-H) vaccine” NCT01546818 ↗ |
| Route | Intramuscular | “Administered Intramuscularly” NCT01546818 ↗ |